With our incredible universities, educated workforce and geographic location, I firmly believe Connecticut can be the next ...

I n this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

Home-grown start-up Mirxes is going places, but co-founder is firmly rooted in Singapore. Read more at straitstimes.com. Read ...

Curogen, one of South Korea's leading biotechnology companies focused on nanotechnology-based treatments for autoimmune diseases, today announced a series of strategic appointments that strengthen its ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Despite challenges, thematic and sector ETFs can have a meaningful role within an intelligently constructed portfolio.

The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector. Biotech stocks lagged the broader market ...